Spanish Pharmaceuticals & Biotech Potentially Undervalued Companies

Pharma Mar

Market Cap: €1.4b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.

Laboratorios Farmaceuticos Rovi

Market Cap: €2.8b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Grifols

Market Cap: €7.6b

Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.

Faes Farma

Market Cap: €1.3b

Researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials worldwide.

Almirall

Market Cap: €2.2b

Operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.